MétaCan
Menu
Back to cohort
Record W2062360007 · doi:10.1158/1538-7445.am2011-4512

Abstract 4512: A novel orally-bioavailable salicylic acid-based small molecular Stat3 inhibitor suppress growth of human breast tumor xenografts

2011· article· en· W2062360007 on OpenAlexaff
Xiaolei Zhang, Brent D. G. Page, Peibin Yue, Steven Fletcher, Wei Zhao, Patrick T. Gunning, James Turkson

Bibliographic record

VenueCancer Research · 2011
Typearticle
Languageen
FieldMedicine
TopicCancer Mechanisms and Therapy
Canadian institutionsAmorfix (Canada)
Fundersnot available
KeywordsSTAT3STAT proteinSurvivinCancer researchCyclin D1Stromal cellChemistryCell cultureBiologyCellCell biologySignal transductionCell cycleBiochemistryGenetics

Abstract

fetched live from OpenAlex

Abstract With the critical role of aberrantly active Signal Transducer and Activator of Transcription (Stat) 3 protein in many human cancers, selective small molecular inhibitors targeting the dimerization event would be valuable as therapeutic agents and as chemical probes to clarify the complex biological functions of Stat3. By computational and structural analyses of the interaction between Stat3 and the lead dimerization disruptor, S3I-201.1066, we have designed a diverse set of analogs. We present evidence from in vitro studies that BP-1-102, a structural analog of S3I-201.1066, directly interacts with Stat3, with an affinity (KD) of 504 nM, inhibits in vitro Stat3 DNA-binding activity, with IC50 of 6.8 μM, and selectively inhibits Stat3 activity in human and mouse tumor cell lines that harbor constitutively-active Stat3. By contrast, BP-1-102 has little or no effect on pShc, pJak, pSrc, and pErk levels. Furthermore, BP-1-102 significantly and specifically suppressed the viability, proliferation, and survival of same malignant cell lines harboring aberrant Stat3 at low concentration, with little or no effect on normal NIH3T3 mouse fibroblasts or the mouse thymus epithelial stromal cells (TE-71) that do not harbor aberrant Stat3 activity. Furthermore, treatment of malignant cells harboring aberrant Stat3 activity with BP-1-102 down-regulated the expression of c-Myc, Cyclin D1, Bcl-xL, Survivin, and VEGF, which are known Stat3-regulated genes. These results together strongly suggest the anti-tumor cell effects of BP-1-102 is largely dependent on the inhibition of aberrant Stat3 activity. Significantly, BP-1-102 induced strong antitumor response in mouse xenografts of human breast cancer when administered via intravenous or oral gavage. Our studies identify a novel small-molecule that binds with a high affinity to Stat3 and that blocks Stat3 activation and function, and thereby induces antitumor response in human breast tumor xenografts harboring aberrant Stat3. Key Words: Stat3 inhibitor, antitumor, xenograft, BP-1-102, S3I-201.1066 Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 4512. doi:10.1158/1538-7445.AM2011-4512

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.118
GPT teacher head0.369
Teacher spread0.252 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicCancer Mechanisms and TherapyFrench-language works237,207